Position in ANAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$332,759
-$6,212,041 QoQ
Shares Held
9,000
-95.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
939,254 | $349,092,534 | |
| 2 | CELC |
Celcuity Inc.
|
1,704,318 | $178,305,749 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,927,895 | $160,858,551 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
1,843,504 | $72,117,876 | |
| 5 | VCEL |
Vericel Corp
|
1,459,152 | $64,917,672 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
177,517 | $59,430,916 | |
| 7 | GERN |
Geron Corp
|
42,808,659 | $54,795,083 | |
| 8 | ERAS |
Erasca, Inc.
|
2,700,000 | $49,464,000 |
All Filings in ANAB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $332,759 | 6,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,544,800 | 135,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,169,313 | 626,040 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,127,088 | 321,040 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,897,141 | 102,052 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,481,380 | 414,000 | Shares | Sole | 2025-02-14 | |
| 2022-12-31 | $456,389 | 14,727 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,633,331 | 64,027 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,064,540 | 643,575 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||